60990-39-8

Basic information

• Product Name: Ethanone, 1-(3-bromo-2,4-dihydroxyphenyl)-
• CAS NO: 60990-39-8
• Molecular Formula: C8H7BrO3
• Molecular Weight: 231.046
• Mol File: 60990-39-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-(3-bromo-2,4-dihydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(3-bromo-2,4-dihydroxyphenyl)-(60990-39-8)
• EPA Substance Registry System: Ethanone, 1-(3-bromo-2,4-dihydroxyphenyl)-(60990-39-8)

Safety Data

• Hazardous Substances Data: 60990-39-8(Hazardous Substances Data)

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 6751-75-3 2-bromoresorcinol 
• 75-36-5 acetyl chloride 
• 39503-62-3 1-(3-bromo-2-hydroxy-4-methoxy-phenyl)-ethanone 

Downstream Products

• 850398-70-8 1-(3-ethylsulfanyl-2,4-dihydroxy-phenyl)-ethanone 
• 850398-72-0 1-(5-ethylsulfanyl-2,4-dihydroxy-phenyl)-ethanone 
• 850398-71-9 1-(3,5-bis-ethylsulfanyl-2,4-dihydroxy-phenyl)-ethanone 
• 159216-39-4 3-bromo-2,4-bis(methoxymethoxy)acetophenone 
• 159216-41-8 (+/-)-2-bromo-1,3-bis(methoxymethoxy)-4-<1-(tert-butyl-dimethylsilyloxy)ethyl>benzene 
• 159216-40-7 (+/-)-2-bromo-1,3-bis(methoxymethoxy)-4-(1-hydroxyethyl)benzene 
• 159474-33-6 (2S)-antafumicin B 

Relevant articles and documents

IMIDAZOLE CARBOXAMIDES

The present invention provides certain imidazole carboxamide derivatives, pharmaceutical compositions thereof, methods of using the same and processes for preparing the same.

FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.

Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones

We have identified and synthesized a series of aryl-tetrazoyl acetophenones as positive allosteric potentiators of the metabotropic glutamate receptor 2. Structure activity relationship studies directed toward improving the potency and level of potentiation led to the discovery of 22 (EC50 = 93 nM, 128% potentiation). We have identified and synthesized a series of aryl-tetrazoyl acetophenones as positive allosteric potentiators of the metabotropic glutamate receptor 2. Structure activity relationship studies directed toward improving the potency and level of potentiation led to the discovery of 22 (EC50 = 93 nM, 128% potentiation).